AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehara, S.
Right arrow Articles by Wildberger, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehara, S.
Right arrow Articles by Wildberger, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2003; 180:281-282
© American Roentgen Ray Society


Multiple Myeloma Seen Only on Multidetector CT

Shigeru Ehara

Iwate Medical University Morioka 020-8505 Japan

I read with interest the article entitled "Multidetector CT of the Spine in Multiple Myeloma: Comparison with MR Imaging and Radiography" in the American Journal of Roentgenology [1].

The authors pointed out that MR imaging might not detect lesions that have evident osteolytic change on multidetector CT. However, in our experience and also according to the literature, MR imaging is sensitive, particularly to the localized bone marrow involvement that may be associated with localized bone resorption [2]. In some tumors, such as adult T-cell leukemia, bone resorption without tumor involvement may occur as a result of the secretion of parathyroid hormone—like peptide, but such a phenomenon is not usually seen in patients with multiple myeloma.

The authors did not describe the patients' history of treatment, but some, such as the patient presented in figure 3 [1], have a long history of disease and probably a history of treatment. When treatment of multiple myeloma is effective, bone marrow lesions are replaced by fatty or fibrous tissue [3], but the bone resorption often remains. In these cases, discrepancy occurs between the bone resorption seen on CT and the bone marrow involvement seen on MR imaging.

I think that such a discrepancy might have been avoided by performing CT and MR imaging before treatment only.

References

  1. Mahnken AH, Wildberger JE, Gehbauer G, et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR 2002;178:1429 -1436[Abstract/Free Full Text]
  2. Moulopoulos LA, Varma DGK, Dimopoulos MA, et al. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease. Radiology 1992;185:833 -840[Abstract/Free Full Text]
  3. Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI. Multiple myeloma: MR patterns of response to treatment. Radiology 1994;193:441 -446[Abstract/Free Full Text]

Reply

A. H. Mahnken, G. Gehbauer and J. E. Wildberger

University Hospital University of Technology D-52074 Aachen, Germany

We thank Dr. Ehara for the thoughtful remarks about our article [1] and for pointing out an important fact, that multiple myeloma lesions change their appearance on MR imaging if the treatment is effective [2]. The fact that most of the patients in our study were under treatment may have led to a discrepancy between the bone resorption seen on CT or conventional radiography and the bone marrow involvement observed on MR imaging. However, even if fibrous or fatty tissue replaces a former multiple myeloma lesion, a disruption of the trabecular bone structure stays behind and, with the bone destruction, a potential risk of fracture remains. Therefore, detection of potentially unstable bone lesions is necessary in the clinical course of these patients. Even in our small patient group, one patient with a history of treatment developed a vertebral infraction during follow-up. The causative osseous lesion was initially detected on multidetector CT only.

We absolutely agree with Ehara that the combined use of CT and MR imaging is of particular value in previously untreated patients. Nevertheless, up to 20% of patients, even those in advanced stages of the disease, have normal findings on conventional radiography and MR imaging [3]. Therefore, a highly sensitive tool for the detection of lytic bone lesions is mandatory for the application of the Durie and Salmon classification [4] and the assessment of the risk of fracture. In this respect, CT proved superior to conventional radiography.

The introduction of a fast and efficient multidetector CT assessment of the skeleton, as shown in our study [1], may replace the established conventional radiographic staging in patients who have multiple myeloma. However, new MR imaging techniques, such as perfusion, may be used for prediction of vertebral fracture risk [5]. So far, MR imaging is considered the imaging modality of choice for visualization of therapy response in multiple myeloma, and it allows determination of the prognosis [6].

Therefore, we believe that CT and MR imaging are currently complementary imaging modalities. In our opinion, the combined use of the techniques, especially for the initial staging, may add to the diagnosis.

References

  1. Mahnken AH, Wildberger JE, Gehbauer G, et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR 2002;178:1429 -1436[Abstract/Free Full Text]
  2. Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI. Multiple myeloma: MR patterns of response to treatment. Radiology 1994;193:441 -446[Abstract/Free Full Text]
  3. Lecouvet FE, Vande Berg BC, Malghem J, Maldague BE. Magnetic resonance and computed tomography imaging in multiple myeloma. Semin Musculoskelet Radiol 2001;5:43 -55[Medline]
  4. Durie BG, Salmon SE. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842 -854[Medline]
  5. Scherer A, Wittsack HJ, Engelbrecht V, et al. Does dynamic contrast-enhanced MRI enable recognition of development of vertebral fractures in multiple myeloma? [in German] Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174:984 -990[Medline]
  6. Lecouvet FE, Vande Berg BC, Michaux L, et al. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 1998;209:653 -660[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehara, S.
Right arrow Articles by Wildberger, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehara, S.
Right arrow Articles by Wildberger, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS